Shares in Remote Monitored Systems surged by over 10 percent this afternoon following news that its Pharm 2 Farm mask has now been certified as meeting the required bicompatibility test.
The mask now has achieved the EN14683 standard which means it can be sold in the UK and Europe as a viricidal type IIR mask.
With America’s president kicking off his campaign by encouraging people to wear masks for the next 100 days, investor sentiment is generally strong for face masks.
Pharm2farm uses a patented process for producing and functionalising nanoparticles for various applications including human, animal and crop health. Pharm2farm is a wholly owned subsidiary of Remote Monitored Systems (LON:RMS).